Clearpoint Neuro Stock Cash And Equivalents

CLPT Stock  USD 15.33  1.07  6.52%   
Clearpoint Neuro fundamentals help investors to digest information that contributes to Clearpoint Neuro's financial success or failures. It also enables traders to predict the movement of Clearpoint Stock. The fundamental analysis module provides a way to measure Clearpoint Neuro's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clearpoint Neuro stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Clearpoint Neuro Company Cash And Equivalents Analysis

Clearpoint Neuro's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

 = 

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Clearpoint Neuro Cash And Equivalents

    
  45.14 M  
Most of Clearpoint Neuro's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clearpoint Neuro is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Clearpoint Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Clearpoint Neuro is extremely important. It helps to project a fair market value of Clearpoint Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Clearpoint Neuro's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Clearpoint Neuro's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Clearpoint Neuro's interrelated accounts and indicators.
0.920.07-0.87-0.590.690.281.0-0.43-0.140.42-0.010.610.620.90.760.860.96-0.190.970.910.69
0.92-0.04-0.92-0.740.74-0.060.93-0.53-0.120.59-0.160.420.430.850.610.880.88-0.320.890.860.64
0.07-0.040.010.30.430.580.050.0-0.36-0.460.770.080.10.310.080.40.17-0.60.170.380.48
-0.87-0.920.010.51-0.540.03-0.890.380.14-0.410.19-0.27-0.27-0.74-0.58-0.83-0.870.17-0.88-0.75-0.45
-0.59-0.740.30.51-0.670.3-0.590.680.07-0.780.42-0.46-0.46-0.61-0.49-0.53-0.460.3-0.48-0.58-0.43
0.690.740.43-0.54-0.670.230.67-0.47-0.170.460.170.540.560.840.550.880.68-0.790.680.880.84
0.28-0.060.580.030.30.230.260.22-0.1-0.370.510.610.620.240.510.210.37-0.140.350.340.3
1.00.930.05-0.89-0.590.670.26-0.43-0.140.43-0.040.580.590.890.750.850.97-0.170.970.90.66
-0.43-0.530.00.380.68-0.470.22-0.430.63-0.350.12-0.42-0.42-0.56-0.47-0.4-0.320.17-0.36-0.5-0.32
-0.14-0.12-0.360.140.07-0.17-0.1-0.140.630.08-0.14-0.2-0.2-0.3-0.21-0.2-0.140.08-0.16-0.23-0.13
0.420.59-0.46-0.41-0.780.46-0.370.43-0.350.08-0.720.270.270.410.30.340.27-0.180.290.370.26
-0.01-0.160.770.190.420.170.51-0.040.12-0.14-0.72-0.020.00.16-0.140.190.1-0.290.080.20.45
0.610.420.08-0.27-0.460.540.610.58-0.42-0.20.27-0.021.00.520.890.40.58-0.190.580.60.36
0.620.430.1-0.27-0.460.560.620.59-0.42-0.20.270.01.00.550.890.420.58-0.20.580.620.4
0.90.850.31-0.74-0.610.840.240.89-0.56-0.30.410.160.520.550.620.90.83-0.40.840.950.88
0.760.610.08-0.58-0.490.550.510.75-0.47-0.210.3-0.140.890.890.620.570.74-0.170.760.710.32
0.860.880.4-0.83-0.530.880.210.85-0.4-0.20.340.190.40.420.90.570.88-0.610.880.940.81
0.960.880.17-0.87-0.460.680.370.97-0.32-0.140.270.10.580.580.830.740.88-0.251.00.890.64
-0.19-0.32-0.60.170.3-0.79-0.14-0.170.170.08-0.18-0.29-0.19-0.2-0.4-0.17-0.61-0.25-0.25-0.5-0.56
0.970.890.17-0.88-0.480.680.350.97-0.36-0.160.290.080.580.580.840.760.881.0-0.250.90.64
0.910.860.38-0.75-0.580.880.340.9-0.5-0.230.370.20.60.620.950.710.940.89-0.50.90.85
0.690.640.48-0.45-0.430.840.30.66-0.32-0.130.260.450.360.40.880.320.810.64-0.560.640.85
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition

Clearpoint Cash And Cash Equivalents Changes

Cash And Cash Equivalents Changes

(22.65 Million)

At this time, Clearpoint Neuro's Cash And Cash Equivalents Changes is comparatively stable compared to the past year.
In accordance with the recently published financial statements, Clearpoint Neuro has 45.14 M in Cash And Equivalents. This is 94.5% lower than that of the Health Care Equipment & Supplies sector and 91.91% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.33% higher than that of the company.

Clearpoint Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clearpoint Neuro's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clearpoint Neuro could also be used in its relative valuation, which is a method of valuing Clearpoint Neuro by comparing valuation metrics of similar companies.
Clearpoint Neuro is currently under evaluation in cash and equivalents category among its peers.

Clearpoint Neuro Current Valuation Drivers

We derive many important indicators used in calculating different scores of Clearpoint Neuro from analyzing Clearpoint Neuro's financial statements. These drivers represent accounts that assess Clearpoint Neuro's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Clearpoint Neuro's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap63.1M251.9M232.6M204.8M167.1M83.6M
Enterprise Value59.9M256.0M190.8M189.2M157.9M165.8M

Clearpoint Neuro ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Clearpoint Neuro's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Clearpoint Neuro's managers, analysts, and investors.
Environmental
Governance
Social

Clearpoint Fundamentals

About Clearpoint Neuro Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Clearpoint Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearpoint Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearpoint Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.